Brief: Nuvation Bio To Acquire Anheart Therapeutics In All-Stock Transaction

Nuvation Bio

25/03/2024 13:25

March 25 (Reuters) - Nuvation Bio Inc  NUVB.N :
    * NUVATION BIO TO ACQUIRE ANHEART THERAPEUTICS IN ALL-STOCK
TRANSACTION
    * NUVATION BIO INC - NUVATION BIO WILL CONTINUE TO BE LED BY
ITS
CURRENT MANAGEMENT TEAM
    * NUVATION BIO INC - FOLLOWING DEAL, MIN CUI AND JUNYUAN
JERRY
WANG WILL JOIN NUVATION BIO BOARD OF DIRECTORS
    * NUVATION BIO - AS ANHEART'S PARENT CO AFTER ACQUISITION,
NUVATION BIO WILL OWN ALL OF ANHEART'S ASSETS, INCLUDING
ANHEART'S INTELLECTUAL PROPERTY
    * NUVATION-FORMER SHAREHOLDERS OF ANHEART WILL OWN ABOUT 33%
AND
CURRENT STOCKHOLDERS OF CO WILL OWN ABOUT 67% OF NUVATION BIO ON
FULLY DILUTED BASIS
    * NUVATION BIO INC - ACQUISITION IS EXPECTED TO CLOSE IN Q2
OF
2024

Source text for Eikon:  ID:nBwFHZ7Ba 
Further company coverage:  NUVB.N 

 ((Reuters.Briefs@thomsonreuters.com;))